Mode
Text Size
Log in / Sign up

clobetasol propionate

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of clobetasol propionate

4 trials tracked of clobetasol propionate: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 283 citations.

4Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 2 Phase 2 1
  1. Phase 3 Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) Completed · 283 cited
  2. Phase 3 Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) Completed · 281 cited
  3. Phase 4 Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis Completed
  4. Phase 2 Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.